Castle Hook Partners LP Makes New $53.13 Million Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Castle Hook Partners LP purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 3rd quarter, HoldingsChannel reports. The firm purchased 108,141 shares of the medical equipment provider’s stock, valued at approximately $53,126,000. Intuitive Surgical accounts for about 1.0% of Castle Hook Partners LP’s portfolio, making the stock its 20th biggest holding.

Other hedge funds have also recently added to or reduced their stakes in the company. Ridgewood Investments LLC bought a new stake in Intuitive Surgical in the 2nd quarter valued at about $26,000. Godsey & Gibb Inc. grew its stake in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. LRI Investments LLC bought a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $30,000. LGT Financial Advisors LLC raised its position in shares of Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares during the period. Finally, MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical in the 3rd quarter worth $33,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $538.55 on Thursday. Intuitive Surgical, Inc. has a one year low of $304.50 and a one year high of $552.00. The business’s fifty day moving average price is $507.94 and its 200-day moving average price is $466.79. The stock has a market capitalization of $191.82 billion, a PE ratio of 86.58, a P/E/G ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity

In related news, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the sale, the general counsel now owns 1,595 shares in the company, valued at approximately $757,625. The trade was a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,459 shares of company stock valued at $26,080,251 in the last 90 days. Insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. JPMorgan Chase & Co. upped their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Citigroup lifted their price target on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Mizuho raised their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Stifel Nicolaus lifted their target price on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $526.06.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.